Composition
- Active ingredients
- VALPROIC ACID 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- VALPROIC ACID 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule, delayed releaseThis page
- VALPROIC ACID 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule, delayed releaseNDA022152-003 · Discontinued
- VALPROIC ACID 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule, delayed releaseNDA022152-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA022152.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Stavzor
- Active substance
- valproic acid
- Route
- Oral
- Dosage form
- Capsule, delayed release
- Applicant
- Bionpharma
- Status
- Discontinued
- FDA approval
- 29 Jul 2008
- Application
- NDA022152-002